BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8103343)

  • 1. Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting.
    Chaisson RE; Stanton DL; Gallant JE; Rucker S; Bartlett JG; Moore RD
    AIDS; 1993 Jun; 7(6):857-62. PubMed ID: 8103343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of three clinical case definitions for advanced HIV disease.
    Gallant JE; Somani J; Chaisson RE; Stanton D; Smith M; Quinn TC
    AIDS; 1992 Mar; 6(3):295-9. PubMed ID: 1348946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and epidemiological implications of the Centers for Disease Control/World Health Organization reclassification of AIDS cases.
    Brettle RP; Gore SM; Bird AG; McNeil AJ
    AIDS; 1993 Apr; 7(4):531-9. PubMed ID: 8099489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.
    MMWR Recomm Rep; 1992 Dec; 41(RR-17):1-19. PubMed ID: 1361652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.
    JAMA; 1993 Feb; 269(6):729-30. PubMed ID: 8093740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential survival of patients with AIDS according to the 1987 and 1993 CDC case definitions.
    Vella S; Chiesi A; Volpi A; Giuliano M; Floridia M; Dally LG; Binkin N
    JAMA; 1994 Apr; 271(15):1197-9. PubMed ID: 7908705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the revised CDC case definition of AIDS on the number of AIDS cases in the Sydney AIDS Prospective Study.
    Tindall B; Sharkey T; Kaldor J; Cooper DA
    Aust N Z J Med; 1992 Aug; 22(4):369-73. PubMed ID: 1359862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the revised surveillance definition: AIDS among New York City drug users.
    Des Jarlais DC; Wenston J; Friedman SR; Sotheran JL; Maslansky R; Marmor M; Yancovitz S; Beatrice S
    Am J Public Health; 1992 Nov; 82(11):1531-3. PubMed ID: 1359800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
    Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
    Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the revised AIDS case definition on AIDS reporting in San Francisco: evidence of increased reporting in intravenous drug users.
    Payne SF; Rutherford GW; Lemp GF; Clevenger AC
    AIDS; 1990 Apr; 4(4):335-9. PubMed ID: 2350453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users.
    Alcabes P; Muñoz A; Vlahov D; Friedland G
    Ann Epidemiol; 1994 Jan; 4(1):17-26. PubMed ID: 7911376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of disease in persons with human immunodeficiency virus infection in the United States.
    Farizo KM; Buehler JW; Chamberland ME; Whyte BM; Froelicher ES; Hopkins SG; Reed CM; Mokotoff ED; Cohn DL; Troxler S
    JAMA; 1992 Apr; 267(13):1798-805. PubMed ID: 1347573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple clinical staging system that predicts progression to AIDS using CD4 count, oral thrush, and night sweats.
    Rabeneck L; Crane MM; Risser JM; Lacke CE; Wray NP
    J Gen Intern Med; 1993 Jan; 8(1):5-9. PubMed ID: 8093485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory markers and the risk of developing HIV-1 disease among injecting drug users.
    Alcabes P; Selwyn PA; Davenny K; Hartel D; Buono D; Schoenbaum EE; Klein RS; Friedland GH
    AIDS; 1994 Jan; 8(1):107-15. PubMed ID: 7912083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
    Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
    AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the 1993 European revision of the AIDS case definition in Italy: implications for modelling the HIV epidemic.
    Pezzotti P; Napoli PA; Rezza G; Lazzeri V; Acciai S; Curia R; Crosera C; De Rosa MG
    AIDS; 1997 Jan; 11(1):95-9. PubMed ID: 9110081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing case-definition for AIDS.
    Lancet; 1992 Nov; 340(8829):1199-201. PubMed ID: 1359267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential effect of revising the CDC surveillance case definition for AIDS.
    Stehr-Green JK; Jason JM; Evatt BL
    Lancet; 1988 Mar; 1(8584):520-1. PubMed ID: 2893928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDC-defined diseases and opportunistic infections in Jamaican children with HIV/AIDS.
    Pierre R; Steel-Duncan JC; Evans-Gilbert T; Rodriguez B; Palmer P; Smikle MF; Whorms S; Hambleton I; Figueroa JP; Christie CD
    West Indian Med J; 2004 Oct; 53(5):315-21. PubMed ID: 15675497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.